Biotech Values

[apljack]

RE: NGNM Publication

The article boils down to the following:

Presented is an analysis of 500 cases, comprised of 157 nevi, 167 dysplastic nevi, and 176 melanoma cases. The four-fluor FISH assay correctly identified 83.8% of melanomas, and 98.1% of all benign nevi.

Senitivity=83.8%
Specificity=98.1%

Given that this test is being marketed to Dermatologists and pathologists for "borderline lesions" these are acceptable numbers.

We'll see if this gives the MelanoSite test any traction.